Quantitative hepatitis B surface antigen combined with hepatitis B e antigen as sustained virological response predictors during extended therapy with Peginterferon alfa-2a for hepatitis B e antigen-positive chronic hepatitis B

Quantitative serum HBsAg at week 48 and HBsAg level combined with HBeAg loss at week 72 of treatment can predict sustained virological response (SVR) to 96 weeks extended therapy with Peginterferon for chronic hepatitis B patients with poor response to the initial 48 weeks of Peginterferon treatment.
Source: Journal of Clinical Virology - Category: Virology Authors: Source Type: research